Dr. Lal PathLabs Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -1,651.70 +85.05 (5.43%)Updated : 08 May 2026
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 3,146.00 | 2,716.79 | 2,455.96 | 2,385.56 |
| Cash Equivalents | 909.50 | 268.59 | 336.06 | 250.21 |
| Other Liabilities Total | 2.60 | 1.95 | 1.61 | - |
| Common Stock Total | 167.60 | 83.59 | 83.48 | 83.37 |
| Other Current Assets Total | 22.30 | 17.09 | 17.05 | 15.17 |
| Total Assets | 3,146.00 | 2,716.79 | 2,455.96 | 2,385.56 |
| Current Portof LT Debt/ Capital Leases | 53.60 | 54.79 | 143.91 | 136.17 |
| Total Equity | 2,508.20 | 2,172.72 | 1,849.28 | 1,666.30 |
| Long Term Investments | 242.10 | 33.36 | 33.71 | - |
| Retained Earnings( Accumulated Deficit) | 2,340.60 | 1,984.37 | 1,675.91 | 1,501.75 |
| Total Common Shares Outstanding | 16.70 | 16.67 | 16.64 | 16.59 |
| Tangible Book Valueper Share Common Eq | 105.85 | 82.38 | 59.89 | 45.83 |
| Goodwill Net | 548.20 | 548.11 | 548.19 | 547.84 |
| Total Liabilities | 637.80 | 544.07 | 606.68 | 719.26 |
| Total Debt | 199.00 | 157.43 | 246.93 | 419.50 |
| Short Term Investments | 478.40 | 871.45 | 581.66 | 550.58 |
| Cashand Short Term Investments | 1,387.90 | 1,164.07 | 942.60 | 814.31 |
| Total Receivables Net | 112.50 | 125.85 | 111.88 | 95.28 |
| Deferred Income Tax | 6.00 | 3.37 | 2.39 | 2.94 |
| Accounts Receivable- Trade Net | 110.70 | 122.70 | 108.88 | 92.41 |
| Property/ Plant/ Equipment Total- Net | 489.30 | 339.28 | 346.98 | 403.97 |
| Minority Interest | 33.10 | 33.76 | 36.08 | 33.25 |
| Total Current Liabilities | 450.70 | 402.35 | 463.58 | 469.75 |
| Total Inventory | 43.90 | 40.19 | 38.76 | 35.53 |
| Accounts Payable | 180.60 | 198.85 | 186.57 | 156.10 |
| Other Currentliabilities Total | 216.50 | 148.71 | 133.10 | 107.48 |
| Total Long Term Debt | 145.40 | 102.64 | 103.02 | 213.32 |
| Intangibles Net | 192.50 | 251.07 | 304.31 | 358.19 |
| Other Long Term Assets Total | 88.10 | 168.30 | 77.20 | 80.90 |
| Note Receivable- Long Term | 19.20 | 13.16 | 18.89 | 21.58 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,566.60 | 1,363.51 | 1,126.70 | 973.09 |
| Capital Lease Obligations | 145.40 | 102.64 | 103.02 | 129.99 |
| Accumulated Depreciation Total | - | -522.06 | -447.94 | -228.70 |
| Long Term Debt | - | 0.00 | - | 83.33 |
| Other Equity Total | - | -0.55 | -0.61 | -0.46 |
| Prepaid Expenses | - | 16.30 | 16.42 | 12.79 |
| Additional Paid- In Capital | - | 124.79 | 104.89 | 93.49 |
| Cash | - | 24.03 | 24.88 | 13.52 |
| Treasury Stock- Common | - | -19.48 | -14.39 | -11.85 |
| Property/ Plant/ Equipment Total- Gross | - | 857.87 | 790.97 | 629.71 |
| Notes Payable/ Short Term Debt | - | 0.00 | 0.00 | 70.00 |
*All figures in crores except per share values
Dr. Lal PathLabs Quick Links
Dr. Lal PathLabs Dividend Dr. Lal PathLabs Bonus Dr. Lal PathLabs News Dr. Lal PathLabs AGM Dr. Lal PathLabs Rights Dr. Lal PathLabs Splits Dr. Lal PathLabs Board Meetings Dr. Lal PathLabs Key Metrics Dr. Lal PathLabs Shareholdings Dr. Lal PathLabs Profit Loss Dr. Lal PathLabs Cashflow Dr. Lal PathLabs Q1 Results Dr. Lal PathLabs Q2 Results Dr. Lal PathLabs Q3 Results Dr. Lal PathLabs Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
4,513.40+204.90(4.76%)
2,600.00+70.55(2.79%)
1,760.30+27.45(1.58%)
1,019.55-72.25 (-6.62%)
954.60-17.95 (-1.85%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.